PRECLINICAL SERVICES FOR BIOPHARMACEUTICAL PRODUCT DEVELOPMENT: TASK F

Information

• Research Project
• 9355838

• ApplicationId

  9355838

• Core Project Number

  N01AI000000

• Full Project Number

  272201600005I-0-27200001-1

• Serial Number

• FOA Number

• Sub Project Id

• Project Start Date

  9/1/2016 - 8 years ago

• Project End Date

  8/31/2017 - 7 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2016

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• DYNPORT VACCINE COMPANY, LLC

The Biopharmaceutical Product Development Services program provides services to facilitate preclinical development of materials that are derived from biotechnology processes, such as monoclonal antibodies and derivatives of monoclonal antibodies; recombinant proteins; peptides; nucleic acid based vectors (siRNA, plasmids); and live, modified-live and/or attenuated entities. Services include: product development planning and evaluation; assay development and product characterization; process development and formulation; GMP manufacturing; and regulatory CMC documentation support. The aim is advance translational research for infectious diseases.

IC Name

• Activity

  N01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  11625

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:11625\

• Funding Mechanism

  Non SBIR/STTR Contracts

• Study Section

• Study Section Name

• Organization Name

  DYNPORT VACCINE COMPANY, LLC

• Organization Department

• Organization DUNS

  014130053

• Organization City

  FREDERICK

• Organization State

  MD

• Organization Country

  UNITED STATES

• Organization Zip Code

  217024734

• Organization District

  UNITED STATES